Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients

Sponsor
Sheba Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT00658060
Collaborator
(none)
20
1

Study Details

Study Description

Brief Summary

Familial Mediterranean fever (FMF) is an inherited disorder of unknown etiology, characterized by recurrent episodes of fever, peritonitis and/or pleuritis.

Fever is the cardinal manifestation of FMF and is present in most attacks accompanied by abdominal pain.

Another clinical manifestation in patients with FMF is exertional muscle pain, usually in the thigh, which appears even after minor exercise or physical activity in young patients with generally good health (other than FMF) and in good physical condition. Some patients also complain of ankle edema after relatively minor physical activity, which subsides after a night rest. Although these manifestations are quite common in FMF patients and form part of the minor criteria for the diagnosis, the etiopathogenesis has not been examined.

The purpose of the suggested study is to evaluate and characterize the anatomical and biochemical changes in the muscles of the thigh and in the ankle triggered by physical activity in FMF patients complaining of exertional lower leg myalgias and edema after minor physical exercise.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    20 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Exertional Muscle Fatigue In FMF Patients Evaluated By MRI And MR Spectroscopy Of The Thigh
    Study Start Date :
    Sep 1, 2007

    Arms and Interventions

    Arm Intervention/Treatment
    1

    1.Fulfilling the Tel Hashomer criteria for the diagnosis of FMF [5]. 2.Suffering from episodes of exertional leg pain and or exertional ankle edema 3.18-45 years old 4.On a stable (≥ 2 weeks) dose of oral colchicine therapy 5.Non-smokers

    2

    Control group 1.Healthy subjects 2.18-45 years old 3.Non-smokers

    Outcome Measures

    Primary Outcome Measures

    1. change in spectroscopic appearance of muscle after exertion of muscle thigh [1 hour]

    Secondary Outcome Measures

    1. change in muscle intensity signal after exertion [1 hour]

    2. change in joint effusion status after exertion [1 hour]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Fulfilling the Tel Hashomer criteria for the diagnosis of FMF [5].

    2. Suffering from episodes of exertional leg pain and or exertional ankle edema

    3. 18-45 years old

    4. On a stable (≥ 2 weeks) dose of oral colchicine therapy

    5. Non-smokers

    Exclusion Criteria:
    1. with known peripheral vascular disease (PVD) and/or multiple risk factors for PVD (such as diabetes, hypertension, hyperlipidemia)

    2. Suffering from muscular or neurological diseases not related to FMF

    3. With elevated serum creatinine / liver enzymes/ creatine phosphokinase (CPK) levels.

    4. Suffering from claustrophobia, or with metal fragments in body tissue, or with other contraindications for MRI.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sheba Medical Center Ramat Gan Israel 52621

    Sponsors and Collaborators

    • Sheba Medical Center

    Investigators

    • Principal Investigator: Iris Eshed, MD, Sheba Medical Center
    • Principal Investigator: Tammi Kushnir, PhD, Sheba Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00658060
    Other Study ID Numbers:
    • SHEBA-07-4632-IE-CTIL
    First Posted:
    Apr 14, 2008
    Last Update Posted:
    Apr 14, 2008
    Last Verified:
    Apr 1, 2008

    Study Results

    No Results Posted as of Apr 14, 2008